Literature DB >> 19581459

Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.

Panagiota Giakkoupi, Olga Pappa, Michalis Polemis, Alkiviadis C Vatopoulos, Vivi Miriagou, Anastasia Zioga, Costas C Papagiannitsis, Leonidas S Tzouvelekis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581459      PMCID: PMC2737892          DOI: 10.1128/AAC.00690-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.

Authors:  Gaelle Cuzon; Thierry Naas; Marie Claude Demachy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  Identification of Klebsiella pneumoniae carbapenemase in Sweden.

Authors:  Karin Tegmark Wisell; S Haeggman; L Gezelius; O Thompson; I Gustafsson; T Ripa; B Olsson-Liljequist
Journal:  Euro Surveill       Date:  2007-12-20

5.  Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.

Authors:  A Loli; L S Tzouvelekis; E Tzelepi; A Carattoli; A C Vatopoulos; P T Tassios; V Miriagou
Journal:  J Antimicrob Chemother       Date:  2006-07-26       Impact factor: 5.790

6.  A general method for detecting and sizing large plasmids.

Authors:  B M Barton; G P Harding; A J Zuccarelli
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

Review 7.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.

Authors:  A Vatopoulos
Journal:  Euro Surveill       Date:  2008-01-24

8.  KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone.

Authors:  P Giakoupi; H Maltezou; M Polemis; O Pappa; G Saroglou; A Vatopoulos
Journal:  Euro Surveill       Date:  2009-05-28

9.  Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae.

Authors:  Irene Galani; Panagiota Danai Rekatsina; Despina Hatzaki; Diamantis Plachouras; Maria Souli; Helen Giamarellou
Journal:  J Antimicrob Chemother       Date:  2008-01-25       Impact factor: 5.790

10.  First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.

Authors:  Athanassios Tsakris; Ioulia Kristo; Aggeliki Poulou; Fani Markou; Alexandros Ikonomidis; Spyros Pournaras
Journal:  J Antimicrob Chemother       Date:  2008-09-04       Impact factor: 5.790

  10 in total
  22 in total

1.  Novel VIM metallo-beta-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia.

Authors:  Maria Camila Montealegre; Adriana Correa; David F Briceño; Natalia C Rosas; Elsa De La Cadena; Sory J Ruiz; Maria F Mojica; Ruben Dario Camargo; Ivan Zuluaga; Adriana Marin; John P Quinn; Maria Virginia Villegas
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 2.  Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.

Authors:  G Meletis; D Chatzidimitriou; N Malisiovas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

3.  Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia.

Authors:  L J Rojas; M F Mojica; V M Blanco; A Correa; M C Montealegre; E De La Cadena; J J Maya; R D Camargo; J P Quinn; M V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

4.  First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases.

Authors:  A Correa; M C Montealegre; M F Mojica; J J Maya; L J Rojas; E P De La Cadena; S J Ruiz; M Recalde; F Rosso; J P Quinn; M V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-07-23       Impact factor: 5.191

5.  Emergence of Klebsiella pneumoniae carrying bla(VIM) and bla(KPC) genes.

Authors:  G Meletis; E Tzampaz; E Protonotariou; D Sofianou
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

6.  Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.

Authors:  G Samonis; E Koutsounaki; D E Karageorgopoulos; P Mitsikostas; C Kalpadaki; V Bozionelou; I Bompolaki; J Sgouros; V Taktikou; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-31       Impact factor: 3.267

7.  Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.

Authors:  Sofanne J Ravensbergen; Christina Louka; Mariëtte Lokate; Erik Bathoorn; Spyros Pournaras; Tjip S van der Werf; Wiel C M de Lange; Ymkje Stienstra; Onno W Akkerman
Journal:  Am J Trop Med Hyg       Date:  2017-12-21       Impact factor: 2.345

Review 8.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Management of infections due to KPC-producing Klebsiella pneumoniae.

Authors:  Stanley C Deresinski; Patricia Schirmer
Journal:  F1000 Med Rep       Date:  2009-10-14

10.  Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.

Authors:  G Meletis; N Vavatsi; M Exindari; E Protonotariou; E Sianou; C Haitoglou; D Sofianou; S Pournaras; E Diza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.